Candida auris: Epidemiology and Antifungal Strategy

被引:1
|
作者
Eix, Emily F.
Nett, Jeniel E. [1 ]
机构
[1] Univ Wisconsin Madison, Dept Med, Madison, WI 53706 USA
来源
ANNUAL REVIEW OF MEDICINE | 2025年 / 76卷
关键词
Candida auris; epidemiology; treatment; drug resistance; transmission; antifungal; microbiome; skin colonization; UNITED-STATES; NEW-YORK; CLONAL STRAIN; IN-VITRO; RESISTANT; INFECTIONS; OUTBREAK; DISINFECTANTS; MANAGEMENT; FUNGEMIA;
D O I
10.1146/annurev-med-061523-021233
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Candida auris is a recently emerged fungal pathogen that causes severe infections in healthcare settings around the globe. A feature that distinguishes C. auris from other fungal pathogens is its high capacity to colonize skin, leading to widespread outbreaks in healthcare facilities via patient-to-patient transmission. C. auris can persist on skin or in the surrounding environment for extended periods of time, and it exhibits greater antifungal resistance than other Candida species. These factors pose major obstacles for the prevention and treatment of C. auris infection. Recent reports have identified frequently colonized skin sites, risk factors for developing invasive infection, and patterns of antifungal resistance among C. auris strains, all of which help guide therapeutic options. In this review, we highlight key studies of C. auris epidemiology and antifungal resistance, discussing how these factors influence healthcare-associated transmission and treatment outcomes.
引用
收藏
页码:57 / 67
页数:11
相关论文
共 50 条
  • [41] Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs
    Romera, David
    Jairo Aguilera-Correa, John
    Gadea, Ignacio
    Vinuela-Sandoval, Lourdes
    Garcia-Rodriguez, Julio
    Esteban, Jaime
    JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 68 (09) : 1353 - 1358
  • [42] Recent Antifungal Pipeline Developments against Candida auris: A Systematic Review
    Trevino-Rangel, Rogelio De J.
    Gonzalez, Gloria M.
    Montoya, Alexandra M.
    Rojas, Olga C.
    Elizondo-Zertuche, Mariana
    Alvarez-Villalobos, Neri A.
    JOURNAL OF FUNGI, 2022, 8 (11)
  • [43] Comparative genomics and antifungal susceptibility testing of clinical Candida auris isolates
    Herz, M.
    Barber, A. E.
    Ebner, S.
    Aldejohann, A. M.
    Walther, G.
    Martin, R.
    Kurzai, O.
    MYCOSES, 2021, 64 : 18 - 18
  • [44] Antifungal drug susceptibility of Candida auris isolates from German hospitals
    Martin, R.
    Ebner, S.
    Hamprecht, A.
    Walther, G.
    Wagener, J.
    Kurzai, O.
    MYCOSES, 2018, 61 : 34 - 35
  • [45] Antifungal activity of human antimicrobial peptides targeting apoptosis in Candida auris
    Shaban, Siham
    Patel, Mrudula
    Ahmad, Aijaz
    JOURNAL OF MEDICAL MICROBIOLOGY, 2024, 73 (05)
  • [46] Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris
    Kean, Ryan
    Ramage, Gordon
    MSPHERE, 2019, 4 (04)
  • [47] Candida auris
    Schwartz, Ilan S.
    Dingle, Tanis C.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (31) : E865 - E865
  • [48] Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options
    Orlandi Sardi, Janaina de Cassia
    Silva, Diego Romario
    Soares Mendes-Giannini, Maria Jose
    Rosalen, Pedro Luiz
    MICROBIAL PATHOGENESIS, 2018, 125 : 116 - 121
  • [49] Candida auris
    Saris, Katja
    Meis, Jacques F.
    Voss, Andreas
    CURRENT OPINION IN INFECTIOUS DISEASES, 2018, 31 (04) : 334 - 340
  • [50] Importation, Mitigation, and Genomic Epidemiology of Candida auris at a Large Teaching Hospital
    Lesho, Emil P.
    Bronstein, Melissa Z.
    McGann, Patrick
    Stam, Jason
    Kwak, Yoon
    Maybank, Rosslyn
    McNamara, Jodi
    Callahan, Megan
    Campbell, Jean
    Hinkle, Mary K.
    Walsh, Edward E.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2018, 39 (01): : 53 - 57